The market for generic injectables continues to be plagued by prolonged drug shortages on mission critical medications. This serves to threaten patient safety and the ability of medical professionals to consistently provide quality care. In addition, healthcare providers are forced to manage unpredictable medication prices, creating unnecessary hurdles in delivering cost-effective care. In order to […]
*HealthTrust’s definition of “new technology” is classified as a product that, as compared to existing products:
- Offers significant technological advancements,
- Significantly improves clinical outcomes or patient care (i.e., documented reduction in procedure times, outcomes, lengths of stay, readmissions, infection rates), or
- Significantly streamlines work processes and/or the economics of facility operations (i.e., increase or decrease expenses in supply chain or resource utilization).
Demonstration of this via independent, peer-reviewed publication(s) is beneficial but not required.*
Get recent industry best-practice articles and insights from HealthTrust.